Docoh
Loading...

Mon. 8 Nov 2021, 4:20pm ETBenzinga
In: Earnings, News
ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 10 percent decrease over losses of $(0.10) per share from the same period last year.